Qilong Zhou
Tissue Orientated Property Of Chinese Medicine Key Laboratory Of Sichuan Province
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Hierarchically Targeted Cu-Doped Carbon Dot/Kynurenic Acid@RM Platform for Restoring Mitochondrial Metabolism and Modulating Inflammation in Acute Pancreatitis.
Journal: ACS nano
Published: March 17, 2026
Yin-Huang-Qing-Fei-Capsule derived diosgenin and its optimized nanoconjugate target STAT3 against pulmonary fibrosis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 16, 2026
Corrigendum to "Elucidating the distinctive regulatory effects and mechanisms of active compounds in Salvia miltiorrhiza Bunge via network pharmacology: Unveiling their roles in the modulation of platelet activation and thrombus formation" [Toxicology and Applied Pharmacology volume 484, March 2024, 116871].
Journal: Toxicology and applied pharmacology
Published: December 06, 2025
An Orthogonally Functionalizable Tetrazine Building Block for Dual-Conjugated Bioorthogonal Probes.
Journal: Organic letters
Published: November 24, 2025
Panax notoginseng-derived extracellular vesicles alleviate doxorubicin-induced cardiotoxicity by suppressing p53 activation.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 03, 2025
Innovative strategies for anti-fibrotic drugs discovery from traditional Chinese medicine.
Journal: Chinese herbal medicines
Published: September 29, 2025
Network-guided discovery of Zeqi Decoction as a PPARγ-targeted therapy for pulmonary fibrosis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 21, 2025
The value of macrolides in the adjuvant treatment of pulmonary fibrosis: maybe a panacea.
Journal: Therapeutic advances in respiratory disease
Published: June 24, 2025
Dual-scavenging Mn3O4-PEI nanoparticles targeting ROS and cfDNA for acute pancreatitis therapy.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: February 10, 2025
Indirubin attenuates sepsis by targeting the EGFR/SRC/PI3K and NF-κB/MAPK signaling pathways in macrophages.
Journal: Frontiers in pharmacology
Published: December 09, 2024
Metformin aggravates pancreatitis by regulating the release of oxidised mitochondrial DNA via the frataxin (FXN)/ninjurin 1 (NINJ1) signalling pathway.
Journal: British journal of pharmacology
Published: September 13, 2024
Last Updated: 09/26/2026